Complex of amyloid β peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers

Neurochemical Research

Volumn 33, Issue 3, 2008, Pages 412-421

  Krištofiková, Zdena ^a   Kopecký Jr , Vladimír ^b   Hofbauerová, Kateřina ^b,c   Hovorková, Petra ^a   Řípová, Daniela ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

24 Hydroxycholesterol; Aging; Amyloid peptides; Choline carriers; Hippocampus; Membrane anizotropy; Raman spectroscopy

Indexed keywords

24 HYDROXYCHOLESTEROL; AMYLOID BETA PROTEIN; CARRIER PROTEIN; CHOLESTEROL DERIVATIVE; CHOLINE; HEMICHOLINIUM 3; MEMBRANE LIPID; OXYSTEROL; PEPTIDE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANISOTROPY; ARTICLE; CELL MEMBRANE FLUIDITY; DEPLETION; GROUPS BY AGE; HIPPOCAMPUS; IN VITRO STUDY; MALE; MEMBRANE BINDING; MEMBRANE TRANSPORT; NERVE CELL MEMBRANE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RAMAN SPECTROMETRY; RAT; SYNAPTOSOME;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; ANISOTROPY; CHOLINERGIC AGENTS; DATA INTERPRETATION, STATISTICAL; DIPHENYLHEXATRIENE; FLUORESCENT DYES; HEMICHOLINIUM 3; HIPPOCAMPUS; HYDROXYCHOLESTEROLS; MALE; MEMBRANE FLUIDITY; MEMBRANE TRANSPORT PROTEINS; MEMBRANES; NEUROTRANSMITTER TRANSPORT PROTEINS; RATS; RATS, WISTAR; SPECTRUM ANALYSIS, RAMAN; SYNAPTOSOMES;

RATTUS;

EID: 38949085846     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9443-5     Document Type: Article

References (43)

1. Chauhan NB (2003) Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease. J Lipid Res 44:2019-2029
2. Wood WG, Schroeder F, Igbavboa U, Avdulov NI, Chochina SV (2002) Brain membrane cholesterol domains, aging and amyloid β-peptides. Neurobiol Aging 23:685-694
3. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460-6464
4. Gimpl G, Burger K, Fahrenholz F (1997) Cholesterol as modulator of receptor function. Biochemistry 36:10959-10974
5. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B, Dotti CG (2004) Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167:953-960
6. Arispe N, Doh M (2002) Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP(1-40) and (1-42) peptides. FASEB J 16:1526-1536
7. Björkhem I (2002) Do oxysterols control cholesterol homeostasis? J Clin Invest 110:725-730
8. Reiss AB, Siller KA, Rahman MM, Chan ESL, Ghiso J, de Leon MJ (2004) Cholesterol in neurologic disorders of the elderly: stroke and Alzheimeŕs disease. Neurobiol Aging 25:977-989
9. Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R (2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 41: 2195-2198
10. Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Björkhem I, von Bergmann K, Heun R (2002) 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 36:27-32
11. Schönknecht P, Lütjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K, Beyreuther K, Schröred J (2002) Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett 324:83-85
12. Bretillon L, Sidén A, Wahlund LO, Lütjohann D, Minthon L, Crisby M, Hillert J, Groth CG, Diszfalusy U, Björkhem I (2002) Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett 293:87-90
13. Kölsch H, Lütjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 7:899-902
14. Kölsch H, Lütjohann D, Tulke A, Björkhem I, Rao ML (1999) The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res 818:171-175
15. Yao ZX, Brown RC, Teper G, Greeson I, Papadopoulos V (2002) 22R-Hydroxycholesterol protects neuronal cells from β-amyloid-induced cytotoxicity by binding to β-amyloid peptide. J Neurochem 83:1110-1119
16. Lecanu L, Yao W, Teper GL, Yao Z, Greeson J, Papadopoulos V (2004) Identification of naturally occurring spirostenols preventing β-amyloid-induced neurotoxicity. Steroids 69:1-16
17. Esteban JA (2004) Living with the enemy: a physiological role for the β-amyloid peptide. TRENDS Neurosci 27:1-3
18. Kar S. (2002) Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimeŕs disease pathology. Drug Dev Res 56:248-263
19. Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R (1998) Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem 70:2179-2187
20. Krištofiková Z, Tejkalová H, Klaschka J (2001) Amyloid β peptide 1-40 and the function of rat hippocampal hemicholinium-3 sensitive choline carriers: effects of a proteolytic degradation in vitro. Neurochem Res 26:203-212
21. Kremer J J, Pallitto MM, Sklansky DJ, Murphy RM (2000) Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry 39:10309-10318
22. Kremer JJ, Sklansky DJ, Murphy RM (2001) Profile of changes in lipid bilayer structure caused by β-amyloid peptide. Biochemistry 40:8563-8571
23. Chochina SV, Avdulov NA, Igbavboa U, Clearly JP, O'Hare EO, Wood WG (2001) Amyloid β-peptide 1-40 increases neuronal membrane fluidity: role of cholesterol and brain region. J Lipid Res 42:1292-1297
24. Müller WE, Kirsch C, Eckert GP (2001) Membrane-disordering effects of β-amyloid peptides. Biochem Soc Trans 29:617-623
25. Boksa P, Mykita S, Collier B (1988) Arachidonic acid inhibits choline uptake and depletes acetylcholine content in rat cerebral cortical synaptosomes. J Neurochem 50:1309-1318
26. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
27. Zhang D, Xie Y, Mrozek MF, Ortiz C, Davisson VJ, Ben-Amotz D (2003) Raman detection of proteomic analytes. Anal Chem 75:5703-5709
28. Kopecký V Jr, Baumruk V (2006) Structure of the ring in drop coating deposited proteins and its implication for Raman spectroscopy of biomolecules. Vib Spectrosc 42:184-187
29. Miura T, Thomas GJ Jr. (1995) Raman spectroscopy of proteins and their assemblies. In: Biswas BB, Roy S (eds) Subcellular Biochemistry, vol 24. Plenum Press, New York, pp 55-99
30. -1 in the Raman spectra of tyrosyl residues in proteins and certain model compounds. Biochemistry 14:4870-4876
31. Kapitán J, Baumruk V, Kopecký V Jr, Pohl R, Bour P (2006) Proline zwitterion dynamics in solution, glass, and crystalline state. J Am Chem Soc 128:13451-13462
32. Lambermon MHL, Rappaport RV, McLaurin J (2005) Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation. J Neurochem 95:1667-1676
33. Neves SR, Ram PT, Iyengar R (2002) G protein pathways. Science 296:1636-1639
34. 2+-dependent, ATP-induced conversion of the [3H]hemicholinium-3 binding sites from high- to low-affinity states in rat striatum: effect of protein kinase inhibitors on this affinity conversion and synaptosomal choline transport. J Neurochem 54:1500-1508
35. Ribeiro FM, Alves-Silva J, Volknandt W, Martins-Silva C, Mahmud H, Wilhelm A, Gomez MV, Rylett RJ, Ferguson SSG, Prado VF, Prado MAM (2003) The hemicholinium-3 sensitive high affinity choline transporter is internalized by clathrin-mediated endocytosis and is present in endosomes and synaptic vesicles. J Neurochem 87:136-146
36. Gates J, Ferguson SM, Blakely RD, Apparsundaram S (2004) Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. J Pharmacol Exp Ther 310:536-545
37. Zhang W, Basile AS, Gomeza J, Volpicelli LA, Levey AI, Wess J (2002) Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 22:1709-1717
38. - dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Therapeut 92:21-55
39. North P, Fleischer S (1983) Alteration of synaptic membrane cholesterol/phospholipid ratio using a lipid transfer protein. J Biol Chem 258:1242-1253
40. Yip CM, Darabie AA, McLaurin J (2002) Aβ42-peptide assembly on lipid bilayers. J Mol Biol 318:97-107
41. Krištofiková Z, Říčný J, Kozmiková I, Řípová D, Zach P, Klaschka J. (2006) Sex-dependent actions of amyloid β peptides on hippocampal choline carriers of postnatal rats. Neurochem Res 31:351-360
42. Björkhem I, Andersson U, Ellis E, Alvelius G, Ellegård L, Diczfalusy U, Sjövall J, Einarsson C (2001) From brain to bile. J Biol Chem 276:37004-37010
43. Krištofiková Z, Benešová O, Tejkalová H (1993) Comparison of the effects of aging in vivo and of oxygen free radicals in vitro on high-affinity choline uptake and hemicholinium-3 binding in the rat brain. Arch Gerontol Geriatr 17:179-188